Logo for RedHill Biopharma Ltd

RedHill Biopharma Investor Relations Material

Latest events

Logo for RedHill Biopharma Ltd

Q1 2022

RedHill Biopharma
Logo for RedHill Biopharma

H2 23/24

9 Apr, 2025
Logo for RedHill Biopharma

Corporate Presentation

15 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from RedHill Biopharma Ltd

Access all reports
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company focused on the development and commercialization of treatments for gastrointestinal and infectious diseases. The company markets a portfolio of approved products in the United States and is also engaged in clinical development programs targeting conditions such as Crohn’s disease, Helicobacter pylori infection, and COVID-19. RedHill conducts research and commercial activities both independently and through strategic partnerships. The company is headquartered in Tel Aviv, Israel, and its shares are listed on the NASDAQ.